144 related articles for article (PubMed ID: 35583893)
1. One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer.
Carvalho Â; Guimarães-Teixeira C; Constâncio V; Fernandes M; Macedo-Silva C; Henrique R; Monteiro FJ; Jerónimo C
Biomater Sci; 2022 Jun; 10(12):3296-3308. PubMed ID: 35583893
[TBL] [Abstract][Full Text] [Related]
2. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
3. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
Mondelo-Macía P; García-González J; León-Mateos L; Anido U; Aguín S; Abdulkader I; Sánchez-Ares M; Abalo A; Rodríguez-Casanova A; Díaz-Lagares Á; Lago-Lestón RM; Muinelo-Romay L; López-López R; Díaz-Peña R
Mol Oncol; 2021 Nov; 15(11):2923-2940. PubMed ID: 34465006
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.
Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991
[TBL] [Abstract][Full Text] [Related]
6. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
[TBL] [Abstract][Full Text] [Related]
7. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.
Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831445
[TBL] [Abstract][Full Text] [Related]
9. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer.
Kapeleris J; Müller Bark J; Ranjit S; Irwin D; Hartel G; Warkiani ME; Leo P; O'Leary C; Ladwa R; O'Byrne K; Hughes BGM; Punyadeera C
Heliyon; 2022 Jul; 8(7):e09971. PubMed ID: 35874074
[TBL] [Abstract][Full Text] [Related]
12. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
[TBL] [Abstract][Full Text] [Related]
13. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single-Cell Analysis.
Xu M; Zhao H; Chen J; Liu W; Li E; Wang Q; Zhang L
Cytometry A; 2020 Jan; 97(1):46-53. PubMed ID: 31595638
[TBL] [Abstract][Full Text] [Related]
15. Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer.
Sierra J; Marrugo-Ramirez J; Rodríguez-Trujillo R; Mir M; Samitier J
Sensors (Basel); 2020 Feb; 20(5):. PubMed ID: 32121271
[TBL] [Abstract][Full Text] [Related]
16. EGFR mutation detection of lung circulating tumor cells using a multifunctional microfluidic chip.
Wang Y; Gao W; Wu M; Zhang X; Liu W; Zhou Y; Jia C; Cong H; Chen X; Zhao J
Talanta; 2021 Apr; 225():122057. PubMed ID: 33592778
[TBL] [Abstract][Full Text] [Related]
17. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC.
Mohan S; Foy V; Ayub M; Leong HS; Schofield P; Sahoo S; Descamps T; Kilerci B; Smith NK; Carter M; Priest L; Zhou C; Carr TH; Miller C; Faivre-Finn C; Blackhall F; Rothwell DG; Dive C; Brady G
J Thorac Oncol; 2020 Feb; 15(2):216-230. PubMed ID: 31629061
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study.
Salvianti F; Gelmini S; Mancini I; Pazzagli M; Pillozzi S; Giommoni E; Brugia M; Di Costanzo F; Galardi F; De Luca F; Castiglione F; Messerini L; Pinzani P; Antonuzzo L
Br J Cancer; 2021 Jul; 125(1):94-100. PubMed ID: 33953347
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip.
Qian C; Wu S; Chen H; Zhang X; Jing R; Shen L; Wang X; Ju S; Jia C; Cong H
Clin Exp Med; 2018 May; 18(2):191-202. PubMed ID: 29445889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
